Literature DB >> 33512651

CT texture analysis for prediction of EGFR mutational status and ALK rearrangement in patients with non-small cell lung cancer.

Giorgio Maria Agazzi1, Marco Ravanelli1, Elisa Roca2, Daniela Medicina3, Piera Balzarini3, Carlotta Pessina4, William Vermi3, Alfredo Berruti2, Roberto Maroldi1, Davide Farina1.   

Abstract

PURPOSE: To develop a CT texture-based model able to predict epidermal growth factor receptor (EGFR)-mutated, anaplastic lymphoma kinase (ALK)-rearranged lung adenocarcinomas and distinguish them from wild-type tumors on pre-treatment CT scans.
MATERIALS AND METHODS: Texture analysis was performed using proprietary software TexRAD (TexRAD Ltd, Cambridge, UK) on pre-treatment contrast-enhanced CT scans of 84 patients with metastatic primary lung adenocarcinoma. Textural features were quantified using the filtration-histogram approach with different spatial scale filters on a single 5-mm-thick central slice considered representative of the whole tumor. In order to deal with class imbalance regarding mutational status percentages in our population, the dataset was optimized using the synthetic minority over-sampling technique (SMOTE) and correlations with textural features were investigated using a generalized boosted regression model (GBM) with a nested cross-validation approach (performance averaged over 1000 resampling episodes).
RESULTS: ALK rearrangements, EGFR mutations and wild-type tumors were observed in 19, 28 and 37 patients, respectively, in the original dataset. The balanced dataset was composed of 171 observations. Among the 29 original texture variables, 17 were employed for model building. Skewness on unfiltered images and on fine texture was the most important features. EGFR-mutated tumors showed the highest skewness while ALK-rearranged tumors had the lowest values with wild-type tumors showing intermediate values. The average accuracy of the model calculated on the independent nested validation set was 81.76% (95% CI 81.45-82.06).
CONCLUSION: Texture analysis, in particular skewness values, could be promising for noninvasive characterization of lung adenocarcinoma with respect to EGFR and ALK mutations.

Entities:  

Keywords:  Anaplastic lymphoma kinase; Computed tomography; Epidermal growth factor; Non-small cell lung cancer; Radiomics; Texture analysis

Mesh:

Substances:

Year:  2021        PMID: 33512651     DOI: 10.1007/s11547-020-01323-7

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  22 in total

1.  Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Authors:  Rafael Rosell; Enric Carcereny; Radj Gervais; Alain Vergnenegre; Bartomeu Massuti; Enriqueta Felip; Ramon Palmero; Ramon Garcia-Gomez; Cinta Pallares; Jose Miguel Sanchez; Rut Porta; Manuel Cobo; Pilar Garrido; Flavia Longo; Teresa Moran; Amelia Insa; Filippo De Marinis; Romain Corre; Isabel Bover; Alfonso Illiano; Eric Dansin; Javier de Castro; Michele Milella; Noemi Reguart; Giuseppe Altavilla; Ulpiano Jimenez; Mariano Provencio; Miguel Angel Moreno; Josefa Terrasa; Jose Muñoz-Langa; Javier Valdivia; Dolores Isla; Manuel Domine; Olivier Molinier; Julien Mazieres; Nathalie Baize; Rosario Garcia-Campelo; Gilles Robinet; Delvys Rodriguez-Abreu; Guillermo Lopez-Vivanco; Vittorio Gebbia; Lioba Ferrera-Delgado; Pierre Bombaron; Reyes Bernabe; Alessandra Bearz; Angel Artal; Enrico Cortesi; Christian Rolfo; Maria Sanchez-Ronco; Ana Drozdowskyj; Cristina Queralt; Itziar de Aguirre; Jose Luis Ramirez; Jose Javier Sanchez; Miguel Angel Molina; Miquel Taron; Luis Paz-Ares
Journal:  Lancet Oncol       Date:  2012-01-26       Impact factor: 41.316

2.  Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Authors:  Eunice L Kwak; Yung-Jue Bang; D Ross Camidge; Alice T Shaw; Benjamin Solomon; Robert G Maki; Sai-Hong I Ou; Bruce J Dezube; Pasi A Jänne; Daniel B Costa; Marileila Varella-Garcia; Woo-Ho Kim; Thomas J Lynch; Panos Fidias; Hannah Stubbs; Jeffrey A Engelman; Lecia V Sequist; WeiWei Tan; Leena Gandhi; Mari Mino-Kenudson; Greg C Wei; S Martin Shreeve; Mark J Ratain; Jeffrey Settleman; James G Christensen; Daniel A Haber; Keith Wilner; Ravi Salgia; Geoffrey I Shapiro; Jeffrey W Clark; A John Iafrate
Journal:  N Engl J Med       Date:  2010-10-28       Impact factor: 91.245

3.  Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  S Novello; F Barlesi; R Califano; T Cufer; S Ekman; M Giaj Levra; K Kerr; S Popat; M Reck; S Senan; G V Simo; J Vansteenkiste; S Peters
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

4.  Radiomic Features Are Associated With EGFR Mutation Status in Lung Adenocarcinomas.

Authors:  Ying Liu; Jongphil Kim; Yoganand Balagurunathan; Qian Li; Alberto L Garcia; Olya Stringfield; Zhaoxiang Ye; Robert J Gillies
Journal:  Clin Lung Cancer       Date:  2016-02-16       Impact factor: 4.785

Review 5.  Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer.

Authors:  Chien-Chung Lin; Wei-Lun Huang; Fang Wei; Wu-Chou Su; David T Wong
Journal:  Expert Rev Mol Diagn       Date:  2015-09-30       Impact factor: 5.225

6.  The diagnostic efficacy and safety of endobronchial ultrasound-guided transbronchial needle aspiration as an initial diagnostic tool.

Authors:  Young Rak Choi; Jin Young An; Mi Kyeong Kim; Hye-Suk Han; Ki Hyeong Lee; Si-Wook Kim; Ki Man Lee; Kang Hyeon Choe
Journal:  Korean J Intern Med       Date:  2013-10-29       Impact factor: 2.884

7.  Noninvasive image texture analysis differentiates K-ras mutation from pan-wildtype NSCLC and is prognostic.

Authors:  Glen J Weiss; Balaji Ganeshan; Kenneth A Miles; David H Campbell; Philip Y Cheung; Samuel Frank; Ronald L Korn
Journal:  PLoS One       Date:  2014-07-02       Impact factor: 3.240

8.  CT-guided aspiration lung biopsy for EGFR and ALK gene mutation analysis of lung cancer.

Authors:  Weisheng Lian; Yong Ouyang
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

9.  CT texture analysis of lung adenocarcinoma: can Radiomic features be surrogate biomarkers for EGFR mutation statuses.

Authors:  Dongdong Mei; Yan Luo; Yan Wang; Jingshan Gong
Journal:  Cancer Imaging       Date:  2018-12-14       Impact factor: 3.909

10.  Radiogenomic Models Using Machine Learning Techniques to Predict EGFR Mutations in Non-Small Cell Lung Cancer.

Authors:  Jay Kumar Raghavan Nair; Umar Abid Saeed; Connor C McDougall; Ali Sabri; Bojan Kovacina; B V S Raidu; Riaz Ahmed Khokhar; Stephan Probst; Vera Hirsh; Jeffrey Chankowsky; Léon C Van Kempen; Jana Taylor
Journal:  Can Assoc Radiol J       Date:  2020-02-17       Impact factor: 2.248

View more
  15 in total

Review 1.  A narrative review on current imaging applications of artificial intelligence and radiomics in oncology: focus on the three most common cancers.

Authors:  Simone Vicini; Chandra Bortolotto; Marco Rengo; Daniela Ballerini; Davide Bellini; Iacopo Carbone; Lorenzo Preda; Andrea Laghi; Francesca Coppola; Lorenzo Faggioni
Journal:  Radiol Med       Date:  2022-06-30       Impact factor: 6.313

2.  Radiomics and machine learning analysis based on magnetic resonance imaging in the assessment of liver mucinous colorectal metastases.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Federica Dell'Aversana; Francesca Grassi; Andrea Belli; Lucrezia Silvestro; Alessandro Ottaiano; Guglielmo Nasti; Antonio Avallone; Federica Flammia; Vittorio Miele; Fabiana Tatangelo; Francesco Izzo; Antonella Petrillo
Journal:  Radiol Med       Date:  2022-06-02       Impact factor: 6.313

3.  Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery.

Authors:  Valerio Nardone; Alfonso Reginelli; Roberta Grassi; Giovanna Vacca; Giuliana Giacobbe; Antonio Angrisani; Alfredo Clemente; Ginevra Danti; Pierpaolo Correale; Salvatore Francesco Carbone; Luigi Pirtoli; Lorenzo Bianchi; Angelo Vanzulli; Cesare Guida; Roberto Grassi; Salvatore Cappabianca
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575

Review 4.  Radiomics in medical imaging: pitfalls and challenges in clinical management.

Authors:  Roberta Fusco; Vincenza Granata; Giulia Grazzini; Silvia Pradella; Alessandra Borgheresi; Alessandra Bruno; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Andrea Giovagnoni; Roberto Grassi; Vittorio Miele; Antonio Barile
Journal:  Jpn J Radiol       Date:  2022-03-28       Impact factor: 2.701

Review 5.  Lymph Nodes Evaluation in Rectal Cancer: Where Do We Stand and Future Perspective.

Authors:  Alessandra Borgheresi; Federica De Muzio; Andrea Agostini; Letizia Ottaviani; Alessandra Bruno; Vincenza Granata; Roberta Fusco; Ginevra Danti; Federica Flammia; Roberta Grassi; Francesca Grassi; Federico Bruno; Pierpaolo Palumbo; Antonio Barile; Vittorio Miele; Andrea Giovagnoni
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.964

Review 6.  Deep Learning With Radiomics for Disease Diagnosis and Treatment: Challenges and Potential.

Authors:  Xingping Zhang; Yanchun Zhang; Guijuan Zhang; Xingting Qiu; Wenjun Tan; Xiaoxia Yin; Liefa Liao
Journal:  Front Oncol       Date:  2022-02-17       Impact factor: 6.244

7.  An update on radiomics techniques in primary liver cancers.

Authors:  Vincenza Granata; Roberta Fusco; Sergio Venazio Setola; Igino Simonetti; Diletta Cozzi; Giulia Grazzini; Francesca Grassi; Andrea Belli; Vittorio Miele; Francesco Izzo; Antonella Petrillo
Journal:  Infect Agent Cancer       Date:  2022-03-04       Impact factor: 2.965

8.  Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma.

Authors:  Vincenza Granata; Roberta Fusco; Andrea Belli; Valentina Borzillo; Pierpaolo Palumbo; Federico Bruno; Roberta Grassi; Alessandro Ottaiano; Guglielmo Nasti; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo
Journal:  Infect Agent Cancer       Date:  2022-03-28       Impact factor: 2.965

9.  Magnetic Resonance Features of Liver Mucinous Colorectal Metastases: What the Radiologist Should Know.

Authors:  Vincenza Granata; Roberta Fusco; Federica De Muzio; Carmen Cutolo; Sergio Venanzio Setola; Federica Dell'Aversana; Andrea Belli; Carmela Romano; Alessandro Ottaiano; Guglielmo Nasti; Antonio Avallone; Vittorio Miele; Fabiana Tatangelo; Antonella Petrillo; Francesco Izzo
Journal:  J Clin Med       Date:  2022-04-15       Impact factor: 4.964

Review 10.  Molecular typing of lung adenocarcinoma with computed tomography and CT image-based radiomics: a narrative review of research progress and prospects.

Authors:  Jing-Wen Ma; Meng Li
Journal:  Transl Cancer Res       Date:  2021-09       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.